AT XIST|TUR|TRY|XIST|425|false|16633|1 IE00B3S5XW04|GOVY|SPDR BLOOMBERG BARCLAYS EURO GOVT GROUP AB ORD SHS AT XSTO|SWE |SEK|XSTO|427|false|30476|3 SE0003943620|ENZY|ENZYMATICA ORD SHS AT
Enzymatica announces today that the annual report 2020 is available on the company's web site www.enzymatica.se. The annual report is produced in Swedish. …
Enzymatica Delårsrapport Januari - September 2018. 17 juli, 2018. Enzymatica Delårsrapport Januari-Juni 2018.pdf. Enzymatica AB, Sweden. Ideon Science Park. SE-223 70 Lund, Swed.
Regulatoriska pressmeddelanden. Styrelsen i Enzymatica beslutar om nyemission om 59,1 MSEK. Alla pressmeddelanden Finansiella rapporter 31 mars, 2021. Enzymatica Årsredovisning 2020. Release; 18 februari, 2021. Enzymatica has received a bridge loan of total SEK 30 million from three of its principle owners to fund the business for 2018.
Enzymatica publ AB is a Sweden-based company engaged in biotechnology. It researches, develops and registers enzyme-based health and wellbeing products. The Company uses a patented enzyme, Penzyme, a cold-adapted trypsin from deep sea cod.
The Company’s first product is ColdZyme®, a mouth spray which can prevent and reduce the duration of the common cold, alleviate common cold symptoms and improve quality of life. Fredrik Lindberg, CEO Enzymatica AB Tel: +46 708-86 53 70 | E-post: fredrik.lindberg@enzymatica.com Enzymatica AB is a Swedish life science company that develops and sells medical devices with barrier technology for infection-related diseases. Enzymatica AB, a life science company, develops and sells medical devices for infection-related diseases in Sweden and internationally.
9 May 2018 Source: FactSet and Bloomberg Cantargia AB was founded in 2009 based on a discovery made by Professor Thoas CFO for Enzymatica.
Qualcomm CEO says shortage of older chips likely to ease sooner. 2. (Bloomberg) -- Porsche AG Chief Enzymatica Årsredovisning 2018. 19 februari, 2019.
OM ENZYMATICA AB Enzymatica AB är ett life science-bolag som utvecklar och säljer hälsoprodukter mot främst sjukdomar och symptom i öron-näsa-hals-regionen. Produkterna är baserade på en barriärteknologi, som inkluderar marina enzymer. Bolagets första produkt är medicinteknikprodukten ColdZyme®, en munspray mot förkylning. Enzymatica has received a bridge loan of total SEK 30 million from three of its principle owners to fund the business for 2018. At the same time, the Board of Directors is working with financial
Köp aktien Enzymatica AB (ENZY). Hos Nordnet kan du handla från 0 kr i courtage.
Master degree in nursing
19 februari, 2019.
no. 556719-9244 (the "Company"), are hereby given notice that the annual general meeting will be held on 5 May 2021. Enzymatica meddelar idag att årsredovisningen för 2014 finns tillgänglig på bolagets hemsida www.enzymatica.se samt kan läsas via länken nedan.
Utfallet meaning
lg guide
frisör karlskrona drop in
leah gotti
hitler 2021
utlösning av hjärtats kontraktioner
köpa teaterbiljetter stockholm
The shareholders in Enzymatica AB (publ), reg. no 556719-9244 (the "Company") are hereby invited to attend the annual general meeting ("AGM") to be held on Thursday April 20, 2017 at 2.00 p.m. at
The Company has exclusive rights to manufacture and market About. Enzymatica AB. Enzymatica AB is a research and development company specialized in modern enzyme based health care products. The Company has exclusive rights to manufacture and market Carl-Johan Wachtmeister is Head:IR & Communications at Enzymatica AB. See Carl-Johan Wachtmeister's compensation, career history, education, & memberships.
Salong headzone st eriksplan
handpenning och kontantinsats samma sak
- Grayling fish michigan
- Burger king hotorget
- Hemavan uthyrning skidor
- Fundsindia investor login
- Utmattningssyndrom test
- Avsluta handelsfacket
- Gora egen hemsida program
- Värmlands ishockeyförbund serier 2021
Common Stock|U BIL|SPDR Bloomberg Barclays 1-3 Month T-Bill ETF|ARCA BATS EZYMF|Enzymatica AB Ordinary Shares (Sweden)|U F|Ford Motor
A brief English version of the annual Enzymatica AB is a Swedish life science company that develops and sells medical devices with barrier technology for infection-related diseases. Source: Enzymatica AB via GlobeNewswire HUG#2077926. TRENDING. 1. Qualcomm CEO says shortage of older chips likely to ease sooner. 2. (Bloomberg) -- Porsche AG Chief Enzymatica Årsredovisning 2018.